Phosphorus activation neutron dosimetry and its application to an 18-MV radiotherapy accelerator.
Neutron fluxes and dose rates in and near the 18-MV x-ray beam of a Therac-20 accelerator were determined with measured activities from the nuclear reactions 31P(n, rho)31Si (fast neutrons) and 31P(n, gamma)32P (thermal neutrons), published cross sections, and neutron energy spectra from Monte Carlo calculations. Measurements were made in the patient plane in air and at a 10-cm depth in a tissue-similar phantom, and in a plane containing the x-ray target. Orthophosphoric acid solution was identified as a suitable and convenient phosphorus dosimeter material. In the 31P activation method, fluxes and dose rates are determined as the product of measured saturation activity per 31P atom and a conversion factor, which depends on the shape of the assumed neutron spectrum. For fast neutrons, which deliver most of the dose, the accuracy error in the saturation activity determinations was shown to be approximately less than 25%. An inconsistency resulting from neglect of the accelerator's adjustable collimator in the Monte Carlo calculations was demonstrated between the measured saturation activities and the theoretical neutron spectra. The maximum neutron dose equivalent rate observed was 5.9 mSv/Gy of x-ray absorbed dose at the accelerator calibration point. Surface dose equivalent rates of the present study are less than those of fluxmeter and remmeter studies at sites outside Therac-20 treatment fields by as much as factors of 2.4 and 2.8, respectively. The phantom study showed that at 18 MV internally produced neutrons have a negligible effect on the neutron field within the patient.
D009502:Neutrons; D010315:Particle Accelerators; D010758:Phosphorus; D011829:Radiation Dosage; D011874:Radiometry / Q000379:methods; D011882:Radiotherapy, High-Energy
D010758:Phosphorus